---
figid: PMC5893867__fimmu-09-00664-g001
figtitle: Fasciola hepatica modulates macrophage activation
organisms:
- Fasciola hepatica
- Homo sapiens
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC5893867
filename: fimmu-09-00664-g001.jpg
figlink: /pmc/articles/PMC5893867/figure/F1/
number: F1
caption: Fasciola hepatica modulates macrophage activation. F. hepatica ES, F. hepatica
  tegumental antigens (FhTeg), and ES-derived enzymes, such as thioredoxin peroxidase
  (Tpx), 2-Cys peroxiredoxin (Prx), and heme-oxygenase-1 (AO-1) drive Mo phenotype
  toward an alternative activation profile. Fatty acid binding protein (Fh12) binds
  the co-receptor CD14 and inhibits LPS-induced TLR4 activation, suppressing the expression
  of IL-12, TNF, IL-6, and IL-1β. F. hepatica Cathepsin L1 (FheCL1) induces TLR3 degradation,
  which impairs LPS-induced TLR4–TRIF-dependent pathway with the consequent inhibition
  of inflammatory cytokine production. The decrease of an inflammatory cytokine milieu
  might promote the inhibition of a Th1 type response favoring a Th2 profile. F. hepatica
  defense molecule 1 (FhHDM-1) has been shown to have the ability to destabilize lysosomal
  acidification, which impairs Mo NLRP3 activation and consequently inflammasome function,
  resulting in the downregulation of IL-1 β production.
papertitle: 'Helminth Infections: Recognition and Modulation of the Immune Response
  by Innate Immune Cells.'
reftext: Claudia Cristina Motran, et al. Front Immunol. 2018;9:664.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9755833
figid_alias: PMC5893867__F1
figtype: Figure
redirect_from: /figures/PMC5893867__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5893867__fimmu-09-00664-g001.html
  '@type': Dataset
  description: Fasciola hepatica modulates macrophage activation. F. hepatica ES,
    F. hepatica tegumental antigens (FhTeg), and ES-derived enzymes, such as thioredoxin
    peroxidase (Tpx), 2-Cys peroxiredoxin (Prx), and heme-oxygenase-1 (AO-1) drive
    Mo phenotype toward an alternative activation profile. Fatty acid binding protein
    (Fh12) binds the co-receptor CD14 and inhibits LPS-induced TLR4 activation, suppressing
    the expression of IL-12, TNF, IL-6, and IL-1β. F. hepatica Cathepsin L1 (FheCL1)
    induces TLR3 degradation, which impairs LPS-induced TLR4–TRIF-dependent pathway
    with the consequent inhibition of inflammatory cytokine production. The decrease
    of an inflammatory cytokine milieu might promote the inhibition of a Th1 type
    response favoring a Th2 profile. F. hepatica defense molecule 1 (FhHDM-1) has
    been shown to have the ability to destabilize lysosomal acidification, which impairs
    Mo NLRP3 activation and consequently inflammasome function, resulting in the downregulation
    of IL-1 β production.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRX
  - PRDX6
  - LY96
  - RETNLB
  - TLR4
  - CD14
  - NDUFA2
  - TRIM69
  - TICAM1
  - IRF6
  - TLR3
  - NLRP3
  - IL10
  - prx
  - th2
  - ticam1
  - tlr3
  - nlrp3
  - olfcg12
  - il10
  - LPS
---
